UA95103C2 - Substituted arylsulfonamides as antiviral agents - Google Patents

Substituted arylsulfonamides as antiviral agents

Info

Publication number
UA95103C2
UA95103C2 UAA200811582A UAA200811582A UA95103C2 UA 95103 C2 UA95103 C2 UA 95103C2 UA A200811582 A UAA200811582 A UA A200811582A UA A200811582 A UAA200811582 A UA A200811582A UA 95103 C2 UA95103 C2 UA 95103C2
Authority
UA
Ukraine
Prior art keywords
antiviral agents
substituted arylsulfonamides
arylsulfonamides
preparation
substituted
Prior art date
Application number
UAA200811582A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Нильс Свенструп
Хольгер Циммерманн
Дагмар КАРТХАУС
Андреас Гьоллер
Дирк Хаймбах
Керстин Хеннингер
Дитер Ланг
Даниэла Паульсен
Бернд Ридль
Рудольф Шоэ-Лооп
Йоахим Шумахер
Тобиас Вунберг
Original Assignee
Аикурис Гмбх & Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38180640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA95103(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Аикурис Гмбх & Ко. Кг filed Critical Аикурис Гмбх & Ко. Кг
Publication of UA95103C2 publication Critical patent/UA95103C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

У заявці описані заміщені арилсульфонаміди формули (І) і способи їх одержання, а також їх застосування для приготування лікарських засобів, призначених для лікування і/або профілактики захворювань, особливо застосування як противірусних засобів, переважно для боротьби із цитомегаловірусами.(I)The application describes substituted arylsulfonamides of formula (I) and methods for their preparation, as well as their use for the preparation of medicaments intended for the treatment and / or prevention of diseases, especially for use as antiviral agents, preferably for the control of cytomegaloviruses. (I)

UAA200811582A 2006-03-03 2007-02-26 Substituted arylsulfonamides as antiviral agents UA95103C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006009928A DE102006009928A1 (en) 2006-03-03 2006-03-03 Substituted arylsulfonamides

Publications (1)

Publication Number Publication Date
UA95103C2 true UA95103C2 (en) 2011-07-11

Family

ID=38180640

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200811582A UA95103C2 (en) 2006-03-03 2007-02-26 Substituted arylsulfonamides as antiviral agents

Country Status (26)

Country Link
US (1) US8318761B2 (en)
EP (1) EP1991529B1 (en)
JP (1) JP5255455B2 (en)
KR (1) KR101447758B1 (en)
CN (1) CN101389607B (en)
AR (1) AR059710A1 (en)
AT (1) ATE451356T1 (en)
AU (1) AU2007222689B2 (en)
BR (1) BRPI0707068A2 (en)
CA (1) CA2642602C (en)
DE (2) DE102006009928A1 (en)
DK (1) DK1991529T3 (en)
ES (1) ES2335316T3 (en)
IL (1) IL193449A (en)
JO (1) JO2581B1 (en)
MX (1) MX2008011264A (en)
PE (1) PE20080136A1 (en)
PL (1) PL1991529T3 (en)
PT (1) PT1991529E (en)
PY (1) PY0705508A (en)
RU (1) RU2423352C2 (en)
TW (1) TWI388559B (en)
UA (1) UA95103C2 (en)
UY (1) UY30178A1 (en)
WO (1) WO2007101573A1 (en)
ZA (1) ZA200807189B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10319612A1 (en) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituted dihydroquinazolines
EP2103316A1 (en) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Hydrophilic polyurethane dispersions
EP2103318A1 (en) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Medical devices with hydrophilic coatings
EP2103317A1 (en) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Medical devices with hydrophilic coatings
EP2103638A1 (en) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Hydrophilic polyurethane solutions
DE102008025614A1 (en) * 2008-05-28 2009-12-03 Bayer Materialscience Ag Hydrophilic polyurethane coatings
DE102008025613A1 (en) * 2008-05-28 2009-12-03 Bayer Materialscience Ag Hydrophilic polyurethane coatings
US8791200B2 (en) 2008-09-04 2014-07-29 Bayer Materialscience Ag TCD based hydrophilic polyurethane dispersions
DE102011101446A1 (en) * 2011-05-10 2012-11-15 Aicuris Gmbh & Co. Kg Production of Dense Bodies (DB)
EP2853532B1 (en) * 2013-09-28 2020-12-09 Instytut Farmakologii Polskiej Akademii Nauk 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III
CN109879817B (en) * 2019-03-19 2020-10-02 扬州大学 Preparation method of mesosulfuron-methyl
RU2738848C1 (en) * 2019-10-24 2020-12-17 Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") Hepatitis b virus (hbv) inhibitor, which is a derivative of n-{3-[6-(dialkylamino)pyridazine-3-yl]phenyl}aryl sulphonamide derivatives and derivatives of n-{4-[6-(dialkylamino)pyridazine-3-yl]phenyl}aryl sulphonamide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (en) 1998-01-23 1999-07-29 Bayer Ag Use of N-aminophenyl sulfonamides for treating or preventing viral infections, particularly herpes
EP1172361A4 (en) 1999-04-19 2002-05-08 Shionogi & Co Sulfonamide derivatives having oxadiazole rings
DE19920790A1 (en) * 1999-05-06 2000-11-09 Bayer Ag Bis-sulfonamides with anti-HCMV activity
DE19930075A1 (en) 1999-06-30 2001-01-04 Bayer Ag New amino and amidosulfonamides as antiviral agents
DE50204780D1 (en) 2001-04-19 2005-12-08 Bayer Healthcare Ag ARYLSULFONAMIDE AS ANTIVIRAL AGENT
DE10138578A1 (en) 2001-08-06 2003-02-27 Bayer Ag Heterocyclylarylsulfonamide

Also Published As

Publication number Publication date
US20090176842A1 (en) 2009-07-09
TW200813034A (en) 2008-03-16
MX2008011264A (en) 2008-09-12
PL1991529T3 (en) 2010-05-31
JP2009529016A (en) 2009-08-13
US8318761B2 (en) 2012-11-27
PY0705508A (en) 2013-01-01
PE20080136A1 (en) 2008-04-18
ATE451356T1 (en) 2009-12-15
RU2008139195A (en) 2010-04-10
BRPI0707068A2 (en) 2011-04-19
CA2642602C (en) 2014-05-13
DK1991529T3 (en) 2010-04-12
IL193449A0 (en) 2009-05-04
DE502007002264D1 (en) 2010-01-21
CN101389607B (en) 2011-09-07
JO2581B1 (en) 2011-02-27
CA2642602A1 (en) 2007-09-13
AU2007222689B2 (en) 2011-11-17
KR20080107456A (en) 2008-12-10
KR101447758B1 (en) 2014-10-06
CN101389607A (en) 2009-03-18
AR059710A1 (en) 2008-04-23
PT1991529E (en) 2010-01-06
AU2007222689A1 (en) 2007-09-13
EP1991529B1 (en) 2009-12-09
JP5255455B2 (en) 2013-08-07
ZA200807189B (en) 2009-12-30
HK1125371A1 (en) 2009-08-07
RU2423352C2 (en) 2011-07-10
EP1991529A1 (en) 2008-11-19
TWI388559B (en) 2013-03-11
WO2007101573A1 (en) 2007-09-13
IL193449A (en) 2013-02-28
ES2335316T3 (en) 2010-03-24
DE102006009928A1 (en) 2007-09-06
UY30178A1 (en) 2007-09-28

Similar Documents

Publication Publication Date Title
UA95103C2 (en) Substituted arylsulfonamides as antiviral agents
NL300933I2 (en) Letermovir
EA200802213A1 (en) METHODS OF TREATING BLOOD DISEASES
SV2009003299A (en) USED DIHYDROPIRIDINE DERIVATIVES AS INHIBITORS OF PROTEIN QUINASE
EA200870193A1 (en) CYTOTOXIC AGENTS, INCLUDING NEW TOMAMYCIN DERIVATIVES, AND THEIR THERAPEUTIC APPLICATION
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
EA201190217A1 (en) SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
TNSN08400A1 (en) Organic compounds and their uses
EA201290267A1 (en) DERIVATIVES OF DIOXABICICLO [3.2.1] OKTAN-2,3,4-TRIOL
UA106367C2 (en) Azadispiro[3.0.4.1]decane derivatives and their uses
UA85559C2 (en) Aminobenzophenone compounds
CL2007002384A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the treatment of psoriasis.
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
CL2007002380A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the therapeutic and / or prophylactic treatment of actinic keratosis.
PT2056804E (en) USE OF 2,5-DIHYDROXYBENZEN DERIVATIVES FOR THE TREATMENT OF EYE DISEASES
MA32841B1 (en) Compounds of cyclondica dipseibeptides and their use as drugs
MX2009010374A (en) Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments.
NO20074780L (en) Heterocyclylamide-substituted imidazoles
JO2999B1 (en) Tricyclic Compound And Pharmaceutical Use Therof
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
ATE508125T1 (en) TRIAZOLOANILINOPYRIMIDENE DERIVATIVES FOR USE AS ANTIVIRAL AGENTS
ATE380188T1 (en) SUBSTITUTED QUINOLONES
MX2010001303A (en) Therapeutic compounds.
UY30135A1 (en) REPLACED QUINOLONES III